On December 14, 2023, the U.S. Food and Drug Administration provided an update related to serious adverse event reporting mandated by the Modernization… read more
ToxStrategies LLC is pleased to announce that Dr. Daniele Wikoff has been appointed as its new Chief Scientific Officer. Having had a key… read more
Two toxicologists from ToxStrategies’ Pharmaceuticals Practice are among the team with a new publication concerning the use of in silico (computer modeling) approaches… read more
ToxStrategies toxicologist Dr. Rayetta Henderson served on a panel that briefed both the U.S. House and Senate on the future regulation of CBD… read more
ToxStrategies scientists Julie Panko, Liz Mittal, and Kara Franke assessed potential worker exposures to 1,3-butadiene during chemical manufacturing and processing of the substance… read more
ToxStrategies’ scientists Camarie Perry, Stephanie Vivanco, Ann Holbrow Verwiel, and Deborah Proctor conducted a regulatory and scientific literature review to develop an acute/short-term… read more
ToxStrategies’ scientists will be participating in The Society of Environmental Toxicology and Chemistry’s (SETAC) 44th Annual Meeting this year, November 12–16, in Louisville,… read more
HEORStrategies provides robust, strategic health economics and outcomes research (HEOR) consulting services to pharma, biotech, and medical device clients!
